Category: Covid-19

As of 3 March 2023, ECDC will de-escalate BA.2, BA.4 and BA.5 from its list of SARS-CoV-2 variants of concern (VOC), as these parental lineages are no longer circulating.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 27 February – 5 March 2023 and includes updates on COVID-19, group A streptococcal infection, influenza and influenza A(H5N1) , Middle East respiratory syndrome coronavirus (MERS-CoV), Mpox, poliomyelitis, Marburg virus disease and the Earthquakes in Türkiye, Syria.

The epidemiological situation of SARS-CoV-2 in humans and animals is continually evolving. To date, animal species known to transmit SARS-CoV-2 are American mink, raccoon dog, cat, ferret, hamster, house mouse, Egyptian fruit bat, deer mouse and white-tailed deer. Among farmed animals, American mink have the highest likelihood to become infected from humans or animals and…

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 19-25 February 2023 and includes updates on the Earthquake in Türkiye and Syria, COVID-19, Influenza A (H5N1), Group A streptococcal infection, and cholera.

Immediate health needs following earthquakes in Türkiye and Syria are mostly related to trauma and the disruption of healthcare, however, infectious disease threats may be concerning in the following two to four weeks.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 12-18 February 2023 and includes updates on the Earthquake in Türkiye and Syria, COVID-19, Marburg virus disease, Group A streptococcal infection, Mpox and Influenza.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5-11 February 2023 and includes updates on streptococcal infection, measles, COVID-19, influenza, the recall of the antibiotic Dicillin from Sandoz in Denmark, and the earthquake in Türkiye and Syria.

High levels of community transmission and the co-circulation of respiratory viruses, such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza, respiratory syncytial virus (RSV) and others can increase pressure on healthcare systems.

ECDC recommends that healthcare facilities maintain and strengthen infection prevention and control (IPC) measures, due to the high community transmission and co-circulation of respiratory viruses such as SARS-CoV-2, influenza, respiratory syncytial virus (RSV) and others. The implementation should be based on an approach that considers all these viruses.

This issue of the Communicable Disease Threats Report (CDTR) covers the period 30 January – 5 February 2023 and includes updates on COVID-19, diphtheriae, mpox, influenza, influenza A (H9N2), influenza (H5N6), MERS-CoV, avian influenza, BSE, and Niaph virus.